For example, choline-acetyltransferase activity in the hippocampus is increased in mild cognitive impairment, which may precede or represent early AD, but is decreased in later stages of the disease raising questions regarding the timing for cholinergic-replacement therapy in AD [269,270]. The gene discussed is CHAT; the disease is Alzheimer disease.